Amphotericin B clinical trials
Also written Fungizone.
Includes 52 studies of Liposomal amphotericin B.
Counted the way a researcher would: Amphotericin B with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Amphotericin B is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Amphotericin B studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 12 Nov 1964 · FUNGIZONE · ANDA 060570 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
73 studies that test it; most in 2008 (6); 1 more planned to start later
| Year | Studies |
|---|---|
| 1997 | 2 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 4 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 29 · Other 60
Gilead Sciences (8) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Drugs for Neglected Diseases (6) · Pfizer (6) · Assistance Publique - Hôpitaux de Paris (3) · Banaras Hindu University (3) · University of Pittsburgh (3) · Hospital Universitário Professor Edgard Santos (2)
Often tested with
Tested in the same studies.
Fluconazole (11) · Miltefosine (5) · Paromomycin (5) · Flucytosine (4) · Voriconazole (4) · Caspofungin (3) · Itraconazole (2) · Olorofim (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Amphotericin B is the comparator. A study of two new drugs counts under both.
- 1Miltefosine · University of Brasilia
- 1Pentoxifylline · University of Brasilia
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test Amphotericin B, phase 3 first.
- Jun 2027Chronic Pulmonary Aspergillosis and Ambisome Aerosol with ItraconazolePhase 3 · Poitiers University Hospital
- Nov 2026Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel DiseasePhase 2 · Assistance Publique - Hôpitaux de Paris
- Dec 2026Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic DysfunctionNot applicable · Southeast University, China
Studies
Open first, then newest update. How each study uses Amphotericin B is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 89
- Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)Not yet recruitingPhase 3Duke UniversityNCT06525389Written as Liposomal Amphotericin B (LAmB)
- Safety and Efficacy of Liposomal Amphotericin B for Patients With Invasive Mold Diseases in Liver Transplant RecipientsNot yet recruitingNot applicableBeijing Friendship HospitalNCT07725874Written as AmBisome (Amphotericin B) Liposome
- Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological PatientsNot yet recruitingNot applicablePeking University People's HospitalNCT07559032Written as Amphotericin B
- Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel DiseaseRecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT07300553Written as Vancomycin /Amphotericin B (Fungizone®) /Gentamicine 80 mg
- Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)Not yet recruitingPhase 3Institute of Tropical Medicine, BelgiumNCT07463040Written as Liposomal Amphotericin B (LAmB)
- Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic DysfunctionNot yet recruitingNot applicableSoutheast University, ChinaNCT07337720Written as LIposomal amphotericin B (L-AmB) treatment
- Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated TalaromycosisNot yet recruitingNot applicableShanghai Public Health Clinical CenterNCT06926569Written as Amphotericin B
- Chronic Pulmonary Aspergillosis and Ambisome Aerosol with ItraconazoleRecruitingPhase 3Poitiers University HospitalNCT03656081Written as inhaled Ambisome®
- Treatment of Mucosal Bolivian LeishmaniasisRecruitingPhase 3Fundacion Nacional de DermatologiaNCT04799236Written as Group 3: Liposomal amphotericin B
- Amphotericin B for Non-HIV Cryptococcal Meningitis PatientsEnrolling by invitationPhase 4Huashan HospitalNCT06178627Written as Amphotericin B 0.5 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks.
- Olorofim Aspergillus Infection StudyCompletedPhase 3F2G LtdNCT05101187Written as AmBisome®
- Human Bioequivalence Study of Amphotericin B Liposome for InjectionCompletedNot applicableSichuan Huiyu Pharmaceutical Co., LtdNCT06977490Written as Amphotericin B Liposome for Injection (strength: 50 mg, Sichuan Huiyu Pharmaceutical Co., Ltd.)
- Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis TreatmentCompletedPhase 2Assistance Publique - Hôpitaux de ParisNCT00467883Written as Liposomal Amphotericin B
- Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution WorkingActive, not recruitingPhase 2/3Sohag UniversityNCT06980493Written as Amphotericine in liposome (Ambisome®)
- CAMB/MAT2203 in Patients With Mucocutaneous CandidiasisCompletedPhase 2Matinas BioPharma Nanotechnologies, Inc.NCT02629419Written as Amphotericin B
- Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the ElderlyCompletedPhase 1/2Hospital Universitário Professor Edgard SantosNCT06449040Written as Liposomal amphotericin B (AmBisome®)
- Bioequivalence of Amphotericin B Liposome for InjectionCompletedPhase 1CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT05913921Written as Amphotericin B liposome for injection
- Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)CompletedPhase 1Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalNCT04267497Written as Amphotericin B Liposomal 50 MG
- Pharmacokinetics and Safety of AmBisome and DKF-5122CompletedPhase 1Dongkook Pharmaceutical Co., Ltd.NCT05749380Written as AmBisome
- Clinical Study of ABCD in the Treatment of Cryptococcal MeningitisStatus unknownNot applicablePeking Union Medical College HospitalNCT05471063Written as Amphotericin B Colloidal Dispersion
See all 89 studies that test Amphotericin B →
Given beside what is tested · 9 — Amphotericin B is usual care or a partner of the new treatment
- Amphotericin Versus Posaconazole for Pulmonary MucormycosisCompletedPhase 2Post Graduate Institute of Medical Education and Research, ChandigarhNCT05468372Written as Liposomal Amphotericin B
- Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary MucormycosisCompletedPhase 2Post Graduate Institute of Medical Education and Research, ChandigarhNCT04502381Written as Intravenous liposomal amphotericin B alone
- The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) StudyCompletedPhase 2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNCT00419770Written as Liposomal amphotericin B
- Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)CompletedPhase 1/2Matinas BioPharma Nanotechnologies, Inc.NCT04031833Written as Amphotericin B
- High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected IndividualsCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00885703Written as Amphotericin B
- Treatment With Tamoxifen in Cryptococcal MeningitisCompletedPhase 2Oxford University Clinical Research Unit, VietnamNCT03112031Written as Amphotericin B
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azarCompletedPhase 2Banaras Hindu UniversityNCT00371995Written as Liposomal amphotericin B and Miltefosine
- Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDSTerminatedPhase 2Novartis PharmaceuticalsNCT00847678Written as Amphotericin B
- Combination Chemotherapy for the Treatment of Indian Kala-AzarCompletedPhase 2Banaras Hindu UniversityNCT00370825Written as Combination therapy with AmBisome and miltefosine
As the comparator · 10 — what is tested is compared with Amphotericin B
- Antifungal Drugs in Pulmonary MucormycosisNot yet recruitingPhase 4Bin CaoNCT06756191Written as Liposomal Amphotericin B
- Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the ElderlyRecruitingPhase 2/3University of BrasiliaNCT06040489Written as Liposomal Amphotericin B
- A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral LeishmaniasisCompletedPhase 2Drugs for Neglected DiseasesNCT05593666Written as AmBisome®
- Liver Transplant European Study Into the Prevention of Fungal InfectionCompletedPhase 3Astellas Pharma IncNCT01058174Written as liposomal amphotericin B
- Micafungin Versus Amphotercine B in Treatment of Invasive Fungal InfectionCompletedPhase 4Ain Shams UniversityNCT06413056Written as Amphotericin B
- Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3Status unknownPhase 3Matinas BioPharma Nanotechnologies, Inc.NCT05541107Written as Amphotericin B
- A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)CompletedPhase 3Merck Sharp & Dohme LLCNCT01293643Written as 100 mg tetracycline hydrochloride /50 mg amphotericin B cream
- Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedPhase 3Astellas Pharma IncNCT00106288Written as Liposomal Amphotericin B
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsCompletedPhase 4Fundacion SEIMC-GESIDANCT01303549Written as Liposomal amphotericin B
- To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala AzarCompletedPhase 3Bharat Serums and Vaccines LimitedNCT00876824Written as Liposomal Amphotericin B
Codes
What other systems call Amphotericin B · ClinicalTrials.gg INT006963
- MeSH (NLM) D000666Amphotericin BConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7XU7A7DROEAMPHOTERICIN BConfirmed FDA, NLM, Wikidata
- RxNorm 732Confirmed FDA, Wikidata
- Wikidata Q412223amphotericin BConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C238Amphotericin BOne source FDA
- DrugBank DB00681One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000666 | Amphotericin B | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7XU7A7DROE | AMPHOTERICIN B | Confirmed FDA, NLM, Wikidata |
| RxNorm | 732 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412223 | amphotericin B | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C238 | Amphotericin B | One source FDA |
| DrugBank | DB00681 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.